Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19.

ABSTRACT:

Implications

This commentary addresses the state of the evidence on tobacco products, nicotine, and COVID-19. The evidence of the effects of smoking on respiratory infections and the immune system in general are examined and the current understanding of tobacco products and risk for SARS-CoV-2 infection and the course of COVID-19 is addressed.

SUBMITTER: Samet JM 

PROVIDER: S-EPMC7953960 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature